COO — The Cooper Companies Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Key stats#
Data provided bySource: Twelve DataPrice data
- Price
- $62.36
- YTD price return
- -23.91%
- YTD total return
- -23.91%
- Next earnings
- Dec 3, 2026
- Market cap
- 11.9B
- Enterprise value
- 14.5B
- Shares outstanding
- 190.2M
- 52W low
- $51.01
- 52W high
- $89.83
- From 52W high
- -30.58%
- From 52W low
- +22.25%
- 52W range
- 29%$51.01–$89.83
- Beta
- 0.82
Volume
- Rel volume
- 0.60×
- 30D volume
- 3.4M
- 30D $ vol
- 199.6M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- +$1.9M
- Insider net 1Y
- +$1.9M
Form 4 transactions by trade date, as filed; latest on file 2026-09-16.
Fundamentals
- Sales (ttm)
- 4.2B
- Sales/share
- $22.28
- EPS (ttm)
- $2.91
- FCF (ttm)
- 678M
- FCF/share
- $3.57
- Book value/share
- $43.80
- Net margin
- 13.46%
- ROE
- 6.85%
- ROA
- 4.50%
- Debt / equity
- 0.23×
- Current ratio
- 1.22
Growth (CAGR, ttm) · 10Y
- Sales
- +4.73%+6.43%+8.29%+8.33%
- Net income
- +39.88%+27.47%-27.85%+8.59%
- FCF
- +64.66%+45.16%+5.21%+10.71%
- Shares
- -4.36%-1.35%-0.73%-0.25%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +43.33%+28.17%-27.63%+8.59%
- Sales/share
- +9.50%+7.89%+9.09%+8.60%
- FCF/share
- +72.16%+47.15%+5.98%+10.99%
- Book value/share
- +4.25%+4.84%+4.95%+12.08%
- Dividend/share
- -50.19%-20.88%-12.42%n/a
- Price
- -9.63%-9.32%-10.07%+3.56%
- Total return
- -9.63%-9.32%-10.07%+3.57%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 21.4×
- P/OI (ttm)
- 21.8×
- Fwd P/E
- 13.3×
- P/S (ttm)
- 2.8×
- P/B (mrq)
- 1.4×
- P/FCF (ttm)
- 17.5×
- EV/EBITDA (fy)
- 15.7×
- EV/Sales (ttm)
- 3.4×
- FCF yield (ttm)
- 5.72%
- Buyback yield (realized, 1y)
- 4.36%
- Shareholder yield (realized, 1y)
- 4.36%
- Buyback yield (cash, ttm)
- 5.43%
- Shareholder yield (cash, ttm)
- 5.43%
Vs own 10Y history
- P/E
- 15th
- P/OI
- 10th
- P/S
- 2nd
- P/B
- 2nd
- P/FCF
- 2nd
Bar = where today’s multiple sits in COO’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).
Performance · price returntotal return · as of 2026-11-06#
Data provided bySource: Twelve DataFundamentals#
Operating income
5Y CAGR +17.0%10Y CAGR +11.2%YoY +26.4%EPS (diluted)
5Y CAGR +9.2%10Y CAGR +6.1%YoY +357.1%Free cash flow
5Y CAGR +19.7%10Y CAGR +11.4%YoY +66.0%TTM: operating cash flow $1B, capex −$355.3M
Q3 2026: operating cash flow $341.7M, capex −$68.7M
Shares (diluted)
5Y +0.8%10Y +1.6%YoY −3.3%Dividend per share
5Y CAGR +5.9%10Y CAGR +2.9%YoY +33.3%About Cooper Companies#
Data provided bySource: Twelve DataThe Cooper Companies, Inc. is a global medical device company focused on vision care and women’s health. Through its CooperVision segment, the company develops, manufactures, and markets a broad range of contact lenses, including daily disposable, toric, multifocal, and specialty products designed to support different vision correction needs. Its CooperSurgical segment provides fertility, reproductive health, and women’s healthcare products and services, including medical devices, diagnostic tools, cryostorage solutions, and office-based surgical products. The Cooper Companies serves eye care professionals, fertility clinics, hospitals, and other healthcare providers across international markets. Headquartered in San Ramon, California, The Cooper Companies, Inc. plays an important role in specialized healthcare by combining consumer-facing vision products with clinical solutions for reproductive and women’s health.
San Ramon, CA·15,000 employees·Medical Instruments & Supplies·coopercos.com·As of Oct 28, 2026
Recent filings#
- Oct 278-K · CooperCompanies Announces Leadership Transition and Board Refreshment
- Sep 16Insider buy · Kurzius Lawrence Erik (Director) bought 20,000 shares for $1.1M on 2 days since Sep 14
- Sep 14Insider buy · Rosebrough Walter M Jr (Director) bought 10,000 shares for $542K on 2 days since Sep 11
- Sep 11Insider buy · Keel Paul A (Director) bought 4,701.015 shares for $250K at $53.18
- Sep 9Earnings · Earnings release — EPS $1.15 vs $1.11 est. (+3.6%); revenue $1.07B (+1% y/y) 14.7%
ETFs holding COO#
30 of the 193 ETFs ChartRow carries live hold COO. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).
| Fund | Name | Filed weight |
|---|---|---|
| VBR | Vanguard Small-Cap Value ETF | 0.3% |
| XLV | Health Care Select Sector SPDR Fund | 0.2% |
| RSP | Invesco S&P 500 Equal Weight ETF | 0.2% |
| VHT | Vanguard Health Care ETF | 0.2% |
| VB | Vanguard Small-Cap ETF | 0.2% |
| IWS | iShares Russell Mid-Cap Value ETF | 0.1% |
| IWR | iShares Russell Midcap ETF | 0.1% |
| SPYV | SPDR Portfolio S&P 500 Value ETF | 0.0% |
Related Healthcare#
Data provided bySource: Twelve Data| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +16.98% | -0.79% |
| JNJ | Johnson & Johnson | +8.42% | +1.43% |
| ABBV | AbbVie Inc. | +9.23% | +1.07% |
| MRK | Merck & Co. Inc. | +3.37% | -0.14% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +4.74% | -0.40% |
| NVS | Novartis AG | +15.46% | +0.38% |
| TMO | Thermo Fisher Scientific Inc. | +5.81% | +2.63% |
| AMGN | Amgen Inc. | +14.36% | +0.03% |
